The article processing charge of USD990 will be waived for all manuscripts submitted to Advances in Biomarker Sciences and Technology (ABST) in 2023.
ABST is a peer-reviewed, fully open access journal that aims to encompass all aspects of biomarker research. Topics covered range from biomarker development to its applications, clinical diagnosis and treatment to molecular epidemiology and toxicology; from precision medicine to drug development, and from nanotechnology to bioinformatics.
ABST focuses on accelerating communication of the latest advances in the field by providing a high-quality forum for the publication of relevant studies. Article types include, but not limited to, general research articles elucidating topics in novel technologies, study designs or mathematical models, invited and selected reviews, as well as short communications and editorials.
Please visit the journal homepage here.